18F-PBR06 ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 17 | Multiple system atrophy | 1 |
17. Multiple system atrophy
Clinical trials : 119 / Drugs : 138 - (DrugBank : 44) / Drug target genes : 59 - Drug target pathways : 111
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05486806 (ClinicalTrials.gov) | February 1, 2023 | 2/8/2022 | Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders | Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders | Neurodegenerative Diseases;sca3;MSA - Multiple System Atrophy;Ataxia;Synucleinopathies | Drug: 18F-PBR06;Radiation: 18F-PBR06 | Brigham and Women's Hospital | NULL | Not yet recruiting | 18 Years | N/A | All | 50 | NULL |